MEF2D anticorps (AA 299-509)
Aperçu rapide pour MEF2D anticorps (AA 299-509) (ABIN7160506)
Antigène
Voir toutes MEF2D AnticorpsReactivité
Hôte
Clonalité
Conjugué
Application
-
-
Épitope
- AA 299-509
-
Réactivité croisée
- Humain, Souris
-
Purification
- >95%, Protein G purified
-
Immunogène
- Recombinant Human Myocyte-specific enhancer factor 2D protein (299-509AA)
-
Isotype
- IgG
-
-
-
-
Indications d'application
- Recommended dilution: WB:1:500-1:5000, IHC:1:200-1:500,
-
Restrictions
- For Research Use only
-
-
-
Format
- Liquid
-
Buffer
-
Preservative: 0.03 % Proclin 300
Constituents: 50 % Glycerol, 0.01M PBS, pH 7.4 -
Agent conservateur
- ProClin
-
Précaution d'utilisation
- This product contains ProClin: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Stock
- -20 °C,-80 °C
-
Stockage commentaire
- Upon receipt, store at -20°C or -80°C. Avoid repeated freeze.
-
-
- MEF2D (Myocyte Enhancer Factor 2D (MEF2D))
-
Autre désignation
- MEF2D
-
Sujet
-
Background: Transcriptional activator which binds specifically to the MEF2 element, 5\\\'-YTA[AT](4)TAR-3\\\', found in numerous muscle-specific, growth factor- and stress-induced genes. Mediates cellular functions not only in skeletal and cardiac muscle development, but also in neuronal differentiation and survival. Plays diverse roles in the control of cell growth, survival and apoptosis via p38 MAPK signaling in muscle-specific and/or growth factor-related transcription. Plays a critical role in the regulation of neuronal apoptosis (By similarity).
Aliases: DKFZp686I1536 antibody, MADS box transcription factor 2 polypeptide D antibody, Mef2d antibody, MEF2D_HUMAN antibody, Myocyte enhancer factor 2D antibody, Myocyte specific enhancer factor 2, polypeptide D antibody, Myocyte specific enhancer factor 2D antibody, Myocyte-specific enhancer factor 2D antibody
-
UniProt
- Q14814
Antigène
-